TDM Flashcards
Highest concentration of drug in the blood; occurs when absorption/distribution exceeds metabolism/excretion
Peak
Lowest concentration of drug in the blood; achieved just before the next dose
Trough
Time required for drug concentration to decrease by half
Half-life
State where drug absorption/distribution equals metabolism/excretion, typically after 5-7 half-lives
Steady state
Lowest drug concentration in the blood that produces adverse response
MTC (Minimum Toxic Concentration)
Lowest drug concentration in the blood that produces desired effect
MEC (Minimum Effective Concentration)
Range between MEC and MTC that produces therapeutic effect
Therapeutic range
Drug dose that produces beneficial effect in 50% of the population
ED50 (Effective Dose 50)
Drug dose that produces adverse effect in 50% of the population
TD50 (Toxic Dose 50)
Drug dose that causes death in 50% of individuals
LD50 (Lethal Dose 50)
Therapeutic index is the ratio that indicates drug safety margin
TD50 to ED50
Analytical technique that uses Rf values for semi-quantitative screening
Thin-layer Chromatography
Formula for Rf
distance migrated by sample component/distance migrated by solvent
Technique for insufficiently volatile and thermolabile compounds; mobile phase is liquid passed over stationary phase in the column
Liquid Chromatography
Type of liquid chromatography with liquid mobile phase and stationary phase in a column
HPLC (High-Performance Liquid Chromatography)
Liquid chromatography with polar stationary phase and nonpolar mobile phase
Normal-phase LC
Liquid chromatography with nonpolar stationary phase and polar mobile phase
Reverse-phase LC
Chromatography method for volatile or easily volatile compounds, including organic molecules and many drugs
Gas Chromatography
Time it takes for a compound to elute; used for solute identification
Retention time
Measurement proportional to the amount of solute present; used for quantification
Peak area or Height
Common detector system in GC or HPLC for solute identification and quantification
Mass spectrometry
Immunoassay using microparticles as solid phase, enzyme label, and fluorogenic substrate; heterogeneous assay
Microparticle enzyme immunoassay (MEIA)
Homogenous immunoassay where enzyme activity as a label is inhibited by antibody binding to antigen-enzyme conjugate
Enzyme-multiplied immunoassay technique (EMIT)
Homogenous immunoassay using polarized light; rate of rotation is inversely proportional to polarization degree and analyte concentration
Fluorescence polarization immunoassay (FPIA)
Drug activity or fate in the body, influenced by absorption, distribution, metabolism, and excretion
Pharmacokinetics
Biochemical and physiological effects of drugs and mechanisms of action, including receptor binding
Pharmacodynamics
Measure: Amount of drug absorbed relative to the quantity given; affected by first-pass metabolism
Bioavailability
Factor affecting absorption of orally administered drugs through the GI tract
Bioavailability and first-pass metabolism
Factor determining drug distribution into interstitial and intracellular spaces
Lipid solubility of the drug
Primary site and enzyme system for drug metabolism
Hepatic microsomes via cytochrome P450 system
Methods of drug excretion
Hepatic or renal clearance, or a combination
Requirement before drug sampling for accurate analysis
Steady state (5-7 half-lives)
Specimen type preferred for most drug assays
Serum
Specimen type suitable for most drugs except Lithium and free drug assays
Heparinized plasma
Reason SST and PST tubes may falsely decrease TCA and anti-arrhythmics
Drug absorption by the gel
Specimen type appropriate for immunosuppressant drugs
EDTA whole blood
Specimen type for aspirin determination via impedance method
Hirudin (from leech)
Time for collecting trough specimens
Before the next dose is administered
Sampling guideline when drug toxicity is suspected
STAT sampling
Cardioactive drugs for treating CHF
Digoxin
Mechanism of action for digoxin
Inhibits Na+-K+-ATPase, decreasing intracellular K+ and increasing intracellular Ca2+ for improved cardiac contraction
Lidocaine, Quinidine, Disopyramide, Procainamide class of TDM
Class I antiarrhythmic drugs (Sodium channel blockers)
Metabolite of Lidocaine that enhances toxicity
Monoethylglycinexylidide (MEGX)
Metabolite of Procainamide with the same physiologic effect as the parent drug
N-acetylprocainamide (NAPA)
Propranolol is an example of
Class II antiarrhythmic drugs (Beta blockers)
Amiodarone is an example of
“Class III antiarrhythmic drugs (Potassium channel blockers)
“Verapamil is an example of”,”Class IV antiarrhythmic drugs (Calcium channel blockers)”
“Treatment for tachyarrhythmias”,”Antiarrhythmics”
“First-generation anticonvulsants for grand mal/tonic-clonic seizure”,”Phenobarbital
Inactive form of phenobarbital
Primidone
Antiepileptic for petit mal/absence seizures
Ethosuximide, Valproic acid (Depakote)
New generation anticonvulsants
Tiagabine, Vigabatrin, Gabapentin, Topiramate, Felbamate
Bronchodilator used for asthma and COPD
Theophylline
Minor metabolite of theophylline; treatment for neonatal apnea
Caffeine
Neuroleptics (major tranquilizers) for schizophrenia
Phenothiazines (chlorpromazine), Butyrophenones (haloperidol), Newer drugs (risperidone, olanzapine, quetiapine, aripiprazole)
Antimanic agent for bipolar disorder
Lithium
Tricyclic antidepressants
Amitriptyline, Imipramine, Doxepin
Selective serotonin reuptake inhibitors (SSRIs)
Fluoxetine (Prozac)
Monoamine oxidase inhibitors (MAOIs)
Clorgyline, Selegiline
Antibiotics used for gram-negative bacterial infections; causes nephrotoxicity and ototoxicity (TOGAK)
Aminoglycosides (tobramycin, gentamicin, amikacin, kanamycin)
Used for gram-positive bacterial infections; may cause Red Man Syndrome (erythemic flushing of extremities)
Vancomycin
Immunosuppressants: Block T lymphocyte function; Cyclosporine is fat-soluble, Tacrolimus is 100x more potent than Cyclosporine and associated with thrombus formation
"”Calcineurin inhibitors (Cyclosporine
Immunosuppresant that is proliferation signal inhibitors
Sirolimus (Rapamycin), Everolimus, Mycophenolate, Leflunomide
Antineoplastic: Inhibits DNA synthesis; requires Leucovorin administration to rescue host cells
Methotrexate
Antineoplastic: alkylating agent used to treat leukemias and lymphomas before bone marrow transplantation
Busulfan